Amanote Research
Register
Sign In
Structure-Based Identification of HIV1 Nucleocapsid Protein Inhibitors Active Against Wild-Type and Drug-Resistant HIV1 Strains
doi 10.1021/acschembio.7b00907.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
HIV1 Integrase Strand Transfer Inhibitors With Reduced Susceptibility to Drug Resistant Mutant Integrases
Novel HIV1 Non-Nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines With High Potency Against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus
A Photochemical Route to Optically Active Hexahydro4Hfuropyranol, a High-Affinity P2 Ligand for HIV1 Protease Inhibitors
Identification of HIV-1 Inhibitors Targeting the Nucleocapsid Protein
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Severe Thrombocytopenia Associated With HIV1 Infection
Kansas Journal of Medicine
HIV1 Protease Inhibitors Incorporating Stereochemically Defined P2 Ligands to Optimize Hydrogen Bonding in the Substrate Envelope
Alterations in Penicillin-Binding Protein 2B From Penicillin-Resistant Wild-Type Strains of Streptococcus Pneumoniae
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Indoleamides Are Active Against Drug-Resistant Mycobacterium Tuberculosis
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Identification and Characterization of Phage Protein and Its Activity Against Two Strains of Multidrug-Resistant Pseudomonas Aeruginosa
Scientific Reports
Multidisciplinary
